{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:59:19Z","timestamp":1785283159231,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jdcr.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:05:13Z","timestamp":1770710713000},"page":"149-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study"],"prefix":"10.1016","volume":"70","author":[{"given":"Erik","family":"Domingues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41572-025-00595-5","article-title":"Bullous pemphigoid","volume":"11","author":"Akbarialiabad","year":"2025","journal-title":"Nat Rev Dis Prim"},{"issue":"8","key":"10.1016\/j.jdcr.2026.02.005_bib2","article-title":"Interventions for bullous pemphigoid","volume":"2023","author":"Singh","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"16","key":"10.1016\/j.jdcr.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.3390\/jcm13164844","article-title":"Omalizumab and dupilumab for the treatment of bullous pemphigoid: a systematic review","volume":"13","author":"Granados-Betancort","year":"2024","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.jdcr.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jid.2016.06.619","article-title":"PDE4 inhibition as potential treatment of epidermolysis bullosa acquisita","volume":"136","author":"Koga","year":"2016","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.jdcr.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/exd.13335","article-title":"Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita","volume":"26","author":"Ludwig","year":"2017","journal-title":"Exp Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626000834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:26:25Z","timestamp":1785281185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":5,"alternative-id":["S2352512626000834"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.02.005","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The treatment of bullous pemphigoid with topical roflumilast 0.3% cream case study","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}